Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Jun 26, 2024

SELL
$8.02 - $8.67 $72 - $78
-9 Reduced 2.58%
340 $2.89 Million
Q1 2024

May 13, 2024

BUY
$8.02 - $8.67 $8,196 - $8,860
1,022 New
1,022 $8.68 Million
Q4 2023

Jun 26, 2024

SELL
$7.78 - $8.62 $5,235 - $5,801
-673 Reduced 65.85%
349 $2.88 Million
Q2 2023

Aug 08, 2023

BUY
$8.04 - $9.0 $64 - $72
8 New
8 $40,000
Q4 2022

Feb 15, 2023

SELL
$5.96 - $8.06 $131 - $177
-22 Reduced 73.33%
8 $39,000
Q3 2022

Nov 03, 2022

BUY
$5.63 - $7.5 $168 - $225
30 New
30 $0

Others Institutions Holding HLN

About Haleon plc


  • Ticker HLN
  • Exchange
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 4,617,290,240
  • Market Cap $44.8B
  • Description
  • Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...
More about HLN
Track This Portfolio

Track Financial Gravity Asset Management, Inc. Portfolio

Follow Financial Gravity Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Gravity Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Financial Gravity Asset Management, Inc. with notifications on news.